KLT
831689
DAYU BIOLOGICAL
871970
Fujian Superpipe
300198
WuHan Hvsen Biotechnology
300871
Ningxia Xiaoming Agriculture&Animal Husbandry
300967
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 13.66%50.06B | 2.36%35.13B | 0.08%22.08B | -5.05%8.92B | 2.90%44.05B | 6.01%34.32B | 1.72%22.06B | -7.02%9.39B | -8.03%42.81B | -6.15%32.38B |
Refunds of taxes and levies | -35.87%38.78M | -67.15%13.38M | -73.47%10.77M | -92.50%1.32M | -84.76%60.47M | -89.63%40.73M | -81.96%40.62M | 188.84%17.59M | 432.17%396.76M | 551.39%392.64M |
Cash received relating to other operating activities | 61.46%645.88M | 229.23%1.2B | 170.84%749.65M | 265.51%770.52M | -1.93%400.03M | -55.04%365.07M | -49.16%276.79M | 113.62%210.81M | 42.37%407.9M | 95.67%811.99M |
Cash inflows from operating activities | 14.02%50.75B | 4.66%36.35B | 2.05%22.84B | 0.72%9.69B | 2.06%44.51B | 3.41%34.73B | -0.35%22.38B | -5.73%9.62B | -7.02%43.61B | -3.98%33.58B |
Goods services cash paid | 21.09%49.28B | 6.01%35.29B | 5.50%22.6B | 5.40%10.11B | -0.32%40.7B | 5.53%33.29B | -1.36%21.42B | -9.12%9.59B | -7.73%40.83B | -7.10%31.55B |
Staff behalf paid | -1.61%979.82M | 1.26%731.12M | 10.27%492.03M | 14.53%274.18M | 11.68%995.87M | 15.11%721.98M | 12.98%446.19M | 25.62%239.4M | 5.24%891.68M | 5.12%627.23M |
All taxes paid | -12.71%493.3M | -20.22%341.98M | -2.76%239.25M | 42.83%106.07M | 10.72%565.15M | 23.89%428.68M | 9.96%246.05M | -49.01%74.26M | 39.03%510.44M | 48.58%346.01M |
Cash paid relating to other operating activities | -14.96%859.97M | -19.61%794.02M | -48.58%503.15M | -64.57%277.42M | 2.81%1.01B | 16.14%987.73M | 96.78%978.44M | 225.45%783.1M | -1.23%983.67M | 34.29%850.49M |
Cash outflows from operating activities | 19.28%51.61B | 4.88%37.16B | 3.22%23.83B | 0.74%10.77B | 0.13%43.27B | 6.17%35.43B | 1.13%23.09B | -3.98%10.69B | -6.98%43.21B | -5.79%33.37B |
Net cash flows from operating activities | -169.55%-862.82M | -15.57%-814.15M | -39.98%-991.45M | -0.91%-1.08B | 210.38%1.24B | -437.77%-704.46M | -91.20%-708.27M | -15.19%-1.07B | -11.42%399.68M | 146.27%208.56M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | ---- | --582.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash received from returns on investments | -82.17%487.19K | 48.86%36.05K | 48.86%36.05K | ---- | 1,260.60%2.73M | -53.33%24.22K | -53.33%24.22K | ---- | -98.16%200.83K | -43.30%51.89K |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 139.92%17.87M | 179.19%18.03M | 447.62%18.11M | -95.74%118.44K | 1,120.72%7.45M | 60,938.93%6.46M | 1,653,265.00%3.31M | --2.78M | -84.93%610.23K | -98.05%10.58K |
Net cash received from disposal of subsidiaries and other business units | --462.52M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.49M | --8.52M |
Cash inflows from investing activities | 4,623.01%480.88M | 9,169.37%600.86M | 444.73%18.14M | -95.74%118.44K | 9.44%10.18M | -24.50%6.48M | -61.16%3.33M | --2.78M | -37.83%9.3M | 1,255.71%8.59M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -46.25%292.82M | -43.59%223.87M | -54.78%145.56M | -58.42%92.71M | 19.29%544.78M | 14.61%396.87M | 23.18%321.89M | 26.11%222.99M | -31.71%456.69M | -35.86%346.27M |
Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 219.91%85M | -84.39%85M |
Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | --16M | ---- | ---- | ---- | ---- | ---- |
Cash outflows from investing activities | -47.78%292.82M | -43.59%223.87M | -54.78%145.56M | -58.42%92.71M | 3.53%560.78M | -7.98%396.87M | 12.43%321.89M | 10.49%222.99M | -55.24%541.69M | -60.23%431.27M |
Net cash flows from investing activities | 134.15%188.06M | 196.57%377M | 60.00%-127.42M | 57.95%-92.59M | -3.42%-550.6M | 7.64%-390.38M | -14.70%-318.56M | -9.11%-220.21M | 55.45%-532.38M | 61.00%-422.69M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | ---- | 174.73%107.14M | 174.73%107.14M | 174.73%107.14M | --107.14M | 23.75%39M | 23.75%39M |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | 174.73%107.14M | --107.14M | --107.14M | --107.14M | 23.75%39M | ---- |
Cash from borrowing | 1.07%8.98B | 11.05%7.76B | 2.45%5.4B | -17.65%2.72B | -1.90%8.88B | -6.50%6.99B | -9.56%5.27B | 20.93%3.3B | -18.15%9.06B | -20.25%7.47B |
Cash received relating to other financing activities | 54.66%7.57B | -13.53%4.57B | -0.65%3.52B | -13.70%1.91B | -11.30%4.9B | 28.10%5.28B | 50.19%3.55B | 53.47%2.21B | -0.52%5.52B | -2.55%4.12B |
Cash inflows from financing activities | 19.18%16.55B | -0.40%12.33B | -0.01%8.92B | -17.66%4.63B | -4.98%13.89B | 6.37%12.38B | 8.47%8.92B | 34.74%5.62B | -12.20%14.62B | -14.65%11.64B |
Borrowing repayment | 2.85%8.68B | -8.81%5.97B | -30.31%3.69B | -55.72%1.31B | -8.56%8.44B | -2.12%6.54B | 10.84%5.29B | 51.23%2.97B | 7.46%9.23B | 8.70%6.68B |
Dividend interest payment | -12.13%488.54M | -6.87%346.1M | -1.56%249.65M | -2.39%121.71M | 12.36%555.96M | 4.41%371.61M | 10.79%253.62M | 6.82%124.69M | -18.70%494.81M | -23.66%355.9M |
-Including:Cash payments for dividends or profit to minority shareholders | -25.46%14.49M | ---- | ---- | ---- | 1,188.64%19.43M | ---- | ---- | ---- | -96.98%1.51M | ---- |
Cash payments relating to other financing activities | 21.66%6.95B | 4.56%4.64B | 46.87%3.57B | 117.69%2.47B | 16.60%5.72B | 9.76%4.44B | -1.12%2.43B | 59.17%1.14B | -23.44%4.9B | -12.91%4.05B |
Cash outflows from financing activities | 9.59%16.12B | -3.52%10.96B | -5.88%7.5B | -7.58%3.91B | 0.58%14.71B | 2.43%11.36B | 6.90%7.97B | 51.40%4.23B | -6.24%14.63B | -1.56%11.09B |
Net cash flows from financing activities | 152.05%428.92M | 34.21%1.37B | 48.98%1.42B | -48.26%720.77M | -7,020.36%-824.12M | 85.74%1.02B | 23.60%955.52M | 1.02%1.39B | -101.11%-11.57M | -76.80%550.42M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 54.97%-13.28M | 69.73%-5.9M | -16.91%-3.84M | -9.12%-6.11M | -223.25%-29.49M | -171.06%-19.51M | -121.32%-3.28M | -195.09%-5.6M | 213.58%23.93M | 641.48%27.46M |
Net increase in cash and cash equivalents | -58.32%-259.13M | 1,109.70%929.06M | 503.28%300.82M | -587.57%-460.42M | -35.99%-163.67M | -125.30%-92.01M | -153.15%-74.59M | -62.49%94.43M | -138.93%-120.35M | -56.79%363.75M |
Add:Begin period cash and cash equivalents | -7.85%1.92B | -7.85%1.92B | -7.85%1.92B | -7.85%1.92B | -5.46%2.08B | -5.46%2.08B | -5.46%2.08B | -4.40%2.08B | 16.31%2.2B | 16.31%2.2B |
End period cash equivalent | -13.49%1.66B | 43.03%2.85B | 10.54%2.22B | -32.98%1.46B | -7.85%1.92B | -22.43%1.99B | -14.30%2.01B | -10.41%2.18B | -5.46%2.08B | -6.17%2.57B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.